Publications by authors named "Mark Hsieh"

Claim this Profile
P
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy.
Thierry O Fischmann, Daniel Malashock, Eunseon Ahn, Hongmei Wang, Komal Pradhan, Mark Hsieh

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating trends in pharmacist e-prescribing: 2019-2022.
Shannon Reidt, Mark Hsieh, Joud Roufael, Sharon Kim, Geeta Panwalkar

J Am Pharm Assoc (2003)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, Marc Andre Bailly, Kalyan Chakravarthy, Mark Hsieh

Commun Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, Marc Andre Bailly, Kalyan Chakravarthy, Mark Hsieh

Commun Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
Marc Bailly, Carl Mieczkowski, Veronica Juan, Essam Metwally, Daniela Tomazela, Mark Hsieh

MAbs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction.
Carl Mieczkowski, Alan Cheng, Thierry Fischmann, Mark Hsieh, Jeanne Baker

Antibodies (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal Antibodies.
Carl Mieczkowski, Soheila Bahmanjah, Yao Yu, Jeanne Baker, Gopalan Raghunathan, Mark Hsieh

Antibodies (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical and Immunological Characterization and Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab.
Beth Hutchins, Gary C Starling, Mark A McCoy, Danuta Herzyk, Frederique M Poulet, Mark Hsieh

Mol Cancer Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexibility of BIV TAR-Tat: models of peptide binding.
Mark Hsieh, Elaine D Collins, Thomas Blomquist, Brooke Lustig

J Biomol Struct Dyn· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis